Jean-Paul’s role is to help supervise, coordinate and operate the Bio-Imaging Platform, which offers state of the art capacities for MRI, PET and SPECT scanning, ultrasound imaging and bone/soft tissues density measurements.
Jean-Paul trained as a physician at Université de Montréal (1975-1980), where he also completed his residency in Nuclear Medicine, leading to a Fellowship of the Royal College of Physicians and Surgeons of Canada in that specialty, as well as to a License from the American Board of Nuclear Medicine. This was followed by a fellowship at Centre hospitalier Frédéric-Joliot, Orsay, France, a research facility of the French Atomic Energy Commission, where he worked on projects studying acute stroke and Alzheimer’s disease with tomographic techniques for measuring cerebral blood flow in vivo in humans. Jean-Paul then came back to Montreal as a staff member in Nuclear Medicine at Hôpital Notre-Dame, which became part of the Centre hospitalier de l’université de Montréal, where he was Chief of the Department of Nuclear Medicine from 1997 till 2000, and where he is still practicing as Professor (Clinical) in the Department of Radiology, Radiation Oncology and Nuclear Medicine of the Faculty of Medicine at Université de Montréal. In the meantime (1992-1994), he completed a Master’s degree in Neuroscience at Université de Montréal, working on monoamine transporters with a goal of developing imaging techniques to quantify those systems with PET imaging.
In 2001, Jean-Paul joined the team of the McConnell Brain Imaging Center, Montreal Neurological Institute, as Medical Director of the PET Unit, a position still occupied to this day; he is also an adjunct Professor in the Department of Neurology and Neurosurgery at McGill University.
Jean-Paul became Associate Director, Bio-Imaging, at PERFORM Centre, in 2014, and splits his time between the clinical world at CHUM (where he mostly does neuro-imaging with PET and SPECT) and research activities at Concordia and McGill, where he is involved mostly in projects on neurodegenerative conditions, sleep disorders and epilepsy, supported by funding from a range of agencies (CIHR, CQDM, Weston Foundation, Parkinson’s Disease Foundation of Canada, …).
Tel: 514-848-2424 ext 4499